Silverberg, J. I., Wollenberg, A., Gold, L. S., Rosso, J. D., Yosipovitch, G., Lio, P., . . . Ständer, S. Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationSilverberg, Jonathan I., et al. Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Adis, Springer Healthcare.
MLA (9th ed.) CitationSilverberg, Jonathan I., et al. Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Adis, Springer Healthcare.